Skip to main content

Table 3 absolute and relative frequencies of adverse events related to sedative groups

From: Oral midazolam vs. intranasal dexmedetomidine plus oral midazolam for sedation of pediatric outpatients: a double-blinded randomized controlled trial

Variables

M group

DM group

P

delirium

2(4.7%)

0

0.495

diplopia

1(2.3%)

0

1.00

nausea and vomiting

2(4.7%)

0

0.495

agitation

2(4.7%)

1 (2.5)

1.00

loss of coordination

0

1(2.5%)

0.482

bradycardia

0

1(2.5%)

0.482

lethargy

0

5(12.5%)*

0.023

  1. *Significant differences (P < 0.05)